We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+13.7%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$58.6B
AUM Growth
+$6.88B
Cap. Flow
+$673M
Cap. Flow %
1.15%
Top 10 Hldgs %
15.13%
Holding
2,345
New
99
Increased
633
Reduced
672
Closed
693

Top Sells

Rank Stock Value
1
ICE icon
Intercontinental Exchange
ICE
+$140M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$134M
3
FDX icon
FedEx
FDX
+$111M
4
KMI icon
Kinder Morgan
KMI
+$88.7M
5
ENB icon
Enbridge
ENB
+$61.3M

Sector Composition

Rank Sector Weight
1 Healthcare 17.63%
2 Financials 15.15%
3 Technology 13.23%
4 Industrials 8.77%
5 Energy 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EPZM
926
DELISTED
Epizyme, Inc
EPZM
$2.52M ﹤0.01%
203,200
UFS
927
DELISTED
DOMTAR CORPORATION (New)
UFS
$2.5M ﹤0.01%
50,455
+4,155
+9% +$198K
RPM icon
928
RPM International
RPM
$13.8B
$2.5M ﹤0.01%
43,120
-39,110
-48% -$2.22M
LXRX icon
929
Lexicon Pharmaceuticals
LXRX
$991M
$2.5M ﹤0.01%
+450,000
New +$2.73M
ALLY icon
930
Ally Financial
ALLY
$13.3B
$2.5M ﹤0.01%
90,819
+4,419
+5% +$115K
QTS
931
DELISTED
QTS REALTY TRUST, INC.
QTS
$2.49M ﹤0.01%
55,383
-5,584
-9% -$233K
OSIS icon
932
OSI Systems
OSIS
$3.58B
$2.49M ﹤0.01%
28,401
-29,175
-51% -$2.44M
NTES icon
933
NetEase
NTES
$79.2B
$2.49M ﹤0.01%
51,500
+12,500
+32% +$594K
CLVS
934
DELISTED
Clovis Oncology, Inc.
CLVS
$2.49M ﹤0.01%
100,200
ATCX
935
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
$2.48M ﹤0.01%
+255,000
New +$2.48M
MELI icon
936
Mercado Libre
MELI
$92.3B
$2.46M ﹤0.01%
4,851
+2,682
+124% +$1.07M
AMED
937
DELISTED
Amedisys
AMED
$2.43M ﹤0.01%
19,735
+9,700
+97% +$1.22M
ULTI
938
DELISTED
Ultimate Software Group Inc
ULTI
$2.4M ﹤0.01%
7,282
SPXC icon
939
SPX Corp
SPXC
$11B
$2.4M ﹤0.01%
68,881
-6,706
-9% -$218K
PBF icon
940
PBF Energy
PBF
$7.43B
$2.38M ﹤0.01%
76,432
+25,532
+50% +$858K
HR icon
941
Healthcare Realty
HR
$7.46B
$2.38M ﹤0.01%
83,200
-3,148
-4% -$87.6K
SCCO icon
942
Southern Copper
SCCO
$141B
$2.37M ﹤0.01%
64,491
+37,411
+138% +$1.2M
TEAM icon
943
Atlassian
TEAM
$24.3B
$2.37M ﹤0.01%
21,089
-100
-0.5% -$10.2K
PINC
944
DELISTED
Premier
PINC
$2.37M ﹤0.01%
68,675
+9,975
+17% +$369K
EVRG icon
945
Evergy
EVRG
$19.8B
$2.33M ﹤0.01%
40,063
+5,525
+16% +$314K
STWD icon
946
Starwood Property Trust
STWD
$6.15B
$2.31M ﹤0.01%
103,205
+21,605
+26% +$471K
RNST icon
947
Renasant Corp
RNST
$4B
$2.3M ﹤0.01%
+67,825
New +$2.42M
ROST icon
948
Ross Stores
ROST
$78.1B
$2.26M ﹤0.01%
24,301
-10,739
-31% -$985K
BOX icon
949
Box
BOX
$4.18B
$2.26M ﹤0.01%
116,985
+1,510
+1% +$31.3K
JAZZ icon
950
Jazz Pharmaceuticals
JAZZ
$16B
$2.26M ﹤0.01%
15,800
+1,500
+10% +$196K

Similar funds

Macquarie Group's Q1 2019 Portfolio in Review

As of Q1 2019, Macquarie Group held 2,345 positions worth $58.6B, up 13% from $51.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Macquarie Group's Q1 2019 filing shows 99 new, 633 increased, 672 reduced and 693 closed positions. Its largest new stake was Takeda Pharmaceutical: 4,781,268 shares worth $97.4M. The largest sale was Intercontinental Exchange, an estimated $140M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Financials and Technology.

  • Macquarie Group's largest Q1 2019 buy was Takeda Pharmaceutical: 4,781,268 shares worth $97.4M.
  • Macquarie Group added most to Broadcom in Q1 2019, an estimated $700M increase.
  • Macquarie Group's biggest Q1 2019 reduction was Intercontinental Exchange, cutting an estimated $140M.
  • Macquarie Group fully exited FCB Financial Holdings, Inc. in Q1 2019, selling an estimated $30.2M.
  • Macquarie Group's ten largest holdings make up 15% of its $58.6B portfolio in Q1 2019.
  • Macquarie Group opened 99 new positions and closed 693 in Q1 2019.
  • Macquarie Group's portfolio value rose 13% quarter-over-quarter to $58.6B.

Based on Macquarie Group's 13F filing for Q1 2019, filed 15 May 2019.